Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
12th Jan 200910:45 amRNSTotal Voting Rights
6th Jan 20093:10 pmRNSNotice of Results
9th Dec 20084:35 pmRNSPrice Monitoring Extension
4th Dec 20082:07 pmRNSTotal Voting Rights
27th Nov 20083:54 pmRNSAnnual Information Update
11th Nov 200810:00 amRNSBlocklisting Interim Review
11th Nov 20089:57 amRNSBlocklisting Interim Review
7th Nov 20081:44 pmRNSDirector/PDMR Shareholding
7th Nov 200810:00 amRNSDirector/PDMR Shareholding
6th Nov 20083:45 pmRNSVoting Rights and Capital
5th Nov 20084:38 pmRNSResult of AGM
5th Nov 20087:00 amRNSInterim Management Statement
29th Oct 20089:16 amRNSAnnual Report and Accounts
1st Oct 20084:04 pmRNSTotal Voting Rights
18th Sep 20087:44 amRNSPress Notice 114 Wilmington Group PLC
18th Sep 20087:00 amRNSFinal Results
15th Sep 20085:39 pmRNSTermination of offer talks
15th Sep 20082:39 pmRNSRule 8.3- Wilmington PLC
15th Sep 200810:55 amBUSEPT Disclosure
11th Sep 200810:52 amBUSEPT Disclosure
11th Sep 200810:51 amRNSEPT Disclosure
10th Sep 20082:15 pmRNSRule 8.3- Wilmington Group PL
10th Sep 200810:31 amBUSEPT Disclosure
8th Sep 20082:20 pmRNSRule 8.3- Wilmington Group PL
8th Sep 20081:25 pmRNSRule 8.3- Wilmington Grp
8th Sep 200810:53 amRNSEPT Disclosure
8th Sep 200810:40 amBUSEPT Disclosure
8th Sep 200810:00 amRNSNotice of Results
5th Sep 200810:40 amBUSEPT Disclosure
5th Sep 200810:19 amRNSEPT Disclosure
4th Sep 200810:50 amBUSEPT Disclosure
3rd Sep 200811:15 amRNSEPT Disclosure
3rd Sep 200810:50 amBUSEPT Disclosure
1st Sep 200811:05 amRNSEPT Disclosure
29th Aug 200811:18 amBUSEPT Disclosure
27th Aug 200810:03 amRNSEPT Disclosure
22nd Aug 200810:11 amBUSEPT Disclosure
22nd Aug 200810:02 amRNSEPT Disclosure
21st Aug 20083:38 pmRNSRule 8.3- Wilmington Group PL
21st Aug 200810:37 amRNSEPT Disclosure
21st Aug 200810:32 amBUSEPT Disclosure
20th Aug 200810:11 amBUSEPT Disclosure
19th Aug 200812:35 pmRNSRule 8.3- Wilmington Group PL
19th Aug 200812:16 pmRNSRule 8.3- (Wilmington Group P
19th Aug 200812:11 pmBUSRule 8.3 - WILMINGTON GROUP PLC ORD GBP 0.05
19th Aug 200811:20 amRNSEPT Disclosure
19th Aug 200810:13 amBUSEPT Disclosure
18th Aug 20089:45 amBUSEPT Disclosure
15th Aug 200810:19 amRNSEPT Disclosure
14th Aug 20082:41 pmRNSRule 8.3- WILMINGTON GROUP PL

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.